Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Abroad (travel likely)Recruiting
Conditions
Primary Immune Deficiency
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) · ccopr@nih.gov · 800-411-1222University of Michigan, Ann Arbor, Michigan, United States
Ankara Medical University, Ankara, Turkey (Türkiye)
Gazi University, Ankara, Turkey (Türkiye)
Hacettepe University, Ankara, Turkey (Türkiye)
Marmara University, Istanbul, Turkey (Türkiye)
Necemttin Erbakan University, Konya, Turkey (Türkiye)
Study leads
Helen C Su, M.D.
Principal Investigator
National Institute of Allergy and Infectious Diseases (NIAID)